These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8975749)

  • 1. Food ingredient review at FDA: recent data and initiatives to improve the process.
    Rulis AM; Tarantino LM
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):224-31. PubMed ID: 8975749
    [No Abstract]   [Full Text] [Related]  

  • 2. Generally recognized as safe (GRAS): history and description.
    Burdock GA; Carabin IG
    Toxicol Lett; 2004 Apr; 150(1):3-18. PubMed ID: 15068820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food contact substances and the need for food safety reform.
    Heckman JH
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):236-9. PubMed ID: 8975751
    [No Abstract]   [Full Text] [Related]  

  • 4. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 5. Origins and causes of the problem: the regulatory context.
    Merrill RA
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):214-7. PubMed ID: 8975747
    [No Abstract]   [Full Text] [Related]  

  • 6. Food industry initiatives to improve the FDA's food ingredient review processes.
    Pape SM
    Food Drug Law J; 1996; 51(3):413-21. PubMed ID: 11797718
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing the review process of food additive and GRAS petitions. Overview of the workshop.
    Hutt PB
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):242-5. PubMed ID: 8975753
    [No Abstract]   [Full Text] [Related]  

  • 8. Can FDA seek restitution or disgorgement?
    Gibbs JN; Fleder JR
    Food Drug Law J; 2003; 58(2):129-47. PubMed ID: 12866549
    [No Abstract]   [Full Text] [Related]  

  • 9. Macronutrient substitutes: are regulatory options possible?
    Degnan FH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S38-41. PubMed ID: 8801616
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH
    Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing the review process of food additive and GRAS petitions. Legislative options and opportunities.
    Finley AM
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):240-1. PubMed ID: 8975752
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the Delaney Clause at the FDA.
    Lorentzen RJ
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):198. PubMed ID: 8672876
    [No Abstract]   [Full Text] [Related]  

  • 13. Workshop "Optimizing the Review Process of Food Additive and GRAS Petitions", April 18, 1996. Welcoming remarks.
    Gori GB
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):213. PubMed ID: 8975746
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA'S food ingredient approval process: Safety assurance based on scientific assessment.
    Rulis AM; Levitt JA
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statutory interpretation--federal Food, Drug, and Cosmetic Act--Third Circuit holds that the FDA can obtain restitution on behalf of consumers--United States v. Lane Labs-USA Inc., 427 F.3d 219 (3d Cir. 2005).
    Harv Law Rev; 2006 Jun; 119(8):2636-43. PubMed ID: 16830436
    [No Abstract]   [Full Text] [Related]  

  • 16. The logistical requirements of current FDA review: format of documentation requested.
    Hattan D
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):232-5. PubMed ID: 8975750
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA clarifies policy on salmonellae in feed, holds workshop on anti-Salmonella additives.
    J Am Vet Med Assoc; 1994 Oct; 205(8):1088. PubMed ID: 7890561
    [No Abstract]   [Full Text] [Related]  

  • 18. Under the law, FDA must grant different standards for new dietary ingredients and food additives.
    Mister S; Hathcock J
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):456-8. PubMed ID: 22310217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of macronutrient substitutes by the Food and Drug Administration.
    Rulis AM
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S47-50. PubMed ID: 8801618
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives on immunotoxicity regulatory guidelines.
    Harling RJ
    Inflamm Res; 1996 Dec; 45 Suppl 2():S69-73. PubMed ID: 8988405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.